Cathy Critchlow, MS, PhD, FACE


Amgen, Inc. 

[email protected]

Cathy Critchlow, MS, PhD, FACE, is Vice President and Head of the Center for Observational Research at Amgen, Inc. and an Affiliate Professor of Epidemiology at the University of Washington.  She earned her bachelor’s degree from Stanford University, and both her master’s degree in biomathematics and her doctorate degree in epidemiology from the University of Washington.  A fellow of the College since 2005, she is also a member of the International Society for Pharmacoepidemiology.

In her current role, Dr. Critchlow leads a function that provides strategic and operational leadership to the design and conduct of epidemiologic research across multiple stakeholders and therapeutic areas. Her group has developed a “Real World Data” (RWD) platform that provides access to HIPAA-compliant health data from over 160 million patients supported by a common data model with visualization and analytic tools based on innovative technologies to generate robust evidence supporting the development of new medicines and surveillance of those medicines following regulatory approval.  Collaborations with academic investigators link the internal RWD platform to external platforms, providing access to additional data within the US, Europe and Asia.  Prior to joining Amgen, Dr. Critchlow was a faculty member in Epidemiology at the University of Washington, where her research focused on infectious disease and reproductive epidemiology.  Dr. Critchlow has served on a number of Advisory Committees for the National Institutes of Health, the Food and Drug Administration and the Centers for Disease Control.  Her service to ACE includes previous membership on the Board of Directors and chairmanship of the Communications Committee.